Digital Tomosynthesis: A New Technique for Imaging Nephrolithiasis. Specific Organ Doses and Effective Doses Compared With Renal Stone Protocol Noncontrast Computed Tomography - 26/01/14

Abstract |
Objective |
To determine organ-specific doses (ODs) and effective dose (ED) for digital tomosynthesis (DT) and compare it with our institutional renal stone protocol noncontrast computed tomography (NCCT).
Methods |
A validated anthropomorphic male phantom was placed supine on a digital GE Definium 8000 radiological scanner. Thermoluminescent dosimeters were placed in 256 locations and used to measure OD. A routine DT study was performed consisting of 2 scout images and 1 tomographic sweep in a 14.2-degree arc over the phantom. Software is used to recreate a series of coronal images from the sweep. ODs were determined as the sum of the doses for the study. Equivalent doses were calculated by multiplying OD with the appropriate tissue weighting factor. ED is the summation of the equivalent doses. OD and ED were determined in a similar fashion (using dosimeters) for a renal stone protocol NCCT and doses were compared.
Results |
ODs for DT are significantly lower compared with NCCT. The ED for NCCT is 3.04 ± 0.34 mSv. The calculated ED for DT is 0.87 ± 0.15 mSv (2 scouts at 0.17 mSv and 0.14 mSv and 1 sweep at 0.56 mSv), P <.0001.
Conclusion |
DT exposes patients to substantially less radiation than NCCT. This is particularly true for radiation-sensitive organs. Further studies are needed to compare the sensitivity and specificity of DT as compared with NCCT. However, its low overall radiation dose makes it an ideal study for the follow-up of recurrent stone formers in the office setting.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: Glenn M. Preminger is a consultant for Mission Pharmacal and Boston Scientific. Michael N. Ferrandino is a proctor for Intuitive Surgical, and Michael E. Lipkin is a consultant for Boston Scientific. The remaining authors declare that they have no relevant financial interests. |
|
| Funding Support: This work was supported in part by a Ferdinand Eisenberger grant of the Deutsche Gesellschaft für Urologie (German Society of Urology), ID NeA1/FE-11 (Andreas Neisius) and by the Endourological Society and Cook Urological (Gaston Astroza). |
Vol 83 - N° 2
P. 282-287 - février 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
